1. Pink Sheet
  2. >>Advanced Technologies
  3. >>AI

AI Assurance Lab Concept Leaves Potential Regulatory Gap

 
• By Derrick Gingery

In an interview with the Pink Sheet, Troy Tazbaz, director of the US FDA's Digital Health Center of Excellence, says the agency lacks authority to regulate assurance labs, which would be used to help AI developers ensure their models are working correctly before submitting them for approval.

AI in drug development
The FDA is investing in AI lifecycle management, Tazbaz said. • Source: Shutterstock

Assurance labs, a potentially key part of the development of artificial intelligence for pharmaceutical use, are not part of the official regulatory process yet, which could raise questions for the US Food and Drug Administration as the technology pushes further into the industry.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from AI

More from Advanced Technologies